Christiana Stamoulis insider trades

Open-market stock purchases and sales by Christiana Stamoulis, Director at Hologic Inc, from SEC Form 4 filings since Feb 3, 2011.

Recent trades

DateStockTradeValue
Apr 7, 2026HOLX Hologic IncSold (not open market)—
Apr 7, 2026HOLX Hologic IncSold (not open market)$286K
Apr 7, 2026HOLX Hologic IncSold (not open market)$290K
Apr 7, 2026HOLX Hologic IncSold (not open market)$305K
Apr 7, 2026HOLX Hologic IncSold (not open market)$347K
Apr 7, 2026HOLX Hologic IncSold (not open market)$359K
Apr 7, 2026HOLX Hologic IncSold (not open market)$372K
Apr 7, 2026HOLX Hologic IncSold (not open market)$330K
Apr 7, 2026HOLX Hologic IncSold (not open market)$346K
Apr 7, 2026HOLX Hologic IncSold (not open market)$356K
Feb 26, 2026HOLX Hologic IncBought (not open market)—
Feb 25, 2026 Keenova Therapeutics plcBought (not open market)—
Dec 19, 2025 Keenova Therapeutics plcSold (not open market)—
Dec 15, 2025 Keenova Therapeutics plcBought (not open market)—
Oct 20, 2025HOLX Hologic IncSold$541K
Oct 20, 2025HOLX Hologic IncBought (not open market)—

Companies traded

  • HOLX Hologic Inc: 6 sales, last Apr 7, 2026
  • INCY Incyte Corp: other filings, last Jul 15, 2025
  • VRTX Vertex Pharmaceuticals Inc / MA: 9 sales, last Jul 30, 2013

Get free alerts when Christiana Stamoulis files a new trade →